Related by context. All words. (Click for frequent words.) 66 Autoimmune Disease 66 Apoptosis 66 Aurora Kinase 66 Cancer Vaccines 65 Hematopoietic 64 Neurogenesis 64 Anti Tumor 64 Macrophage 64 Factor Receptor 64 Antiangiogenic 63 RNAi Therapeutics 63 Hepatocellular Carcinoma 63 Protein Kinase 63 Smooth Muscle 63 Novel Therapeutics 63 Therapeutic Targets 63 Transcription Factor 63 RNAi Therapeutic 63 Galectins 63 Chemoprevention 63 Targeted Therapy 63 Kinase Inhibitor 63 Autoimmune Diseases 63 Systemic Delivery 63 Endothelin 63 Endothelial 63 Squalamine 62 RNA Interference 62 Cancer Stem Cells 62 Breast Cancer Metastasis 62 Progenitor Cells 62 Gene Silencing 62 Clinical Outcome 62 Tyrosine Kinase Inhibitor 62 Small Molecule 62 Metabolic Disease 62 PI3K/mTOR 62 Mesenchymal Stem Cells 62 Transcriptome 62 Cell Transplant 62 Factor VIIa 62 Preclinical Study 62 Therapeutic Antibody 62 chemokine receptor 62 Stromal 62 Innate Immune 61 Kinase Inhibitors 61 histone deacetylase 61 Insulin Resistance 61 Pancreatic 61 Dendritic Cells 61 Hsp# Inhibitor 61 BiTE Antibody 61 Cell Adhesion 61 Epithelial 61 Trodusquemine MSI 61 Curaxin 61 Signaling Pathway 61 Fibroblast 61 Signaling Pathways 61 Vulnerable Plaque 61 Anti Angiogenesis 61 Synthetic Peptide 60 Factor VEGF 60 HER1 60 Autoimmunity 60 Chemokine Receptor 60 Anticancer 60 angiogenesis 60 Lymphoid 60 Anti angiogenic 60 phosphatidylinositol 3 60 Cognitive Deficits 60 Therapeutic Antibodies 60 Novel Therapies 60 Cytokine 60 HDAC Inhibitor 60 selective inhibition 60 Monocytes 60 Ischemic 60 Fibrosis 60 Kinases 60 Recurrent Breast Cancer 60 Tumor Suppressor 60 Aptamer 60 Neuroprotection 60 Ad5FGF 4 60 TNF Alpha 60 Fallopian Tube 60 lymphangiogenesis 60 Angiogenic 60 Neuroprotective Effects 60 vascular disrupting agents 60 Tumor Microenvironment 60 Deforolimus 60 Sipuleucel T 60 Sapacitabine 60 inhibit vascular endothelial 60 Cell Differentiation 60 poly ADP ribose polymerase 60 Blinatumomab 60 Phase 2b Clinical Trial 60 Biological Therapy 60 Antigen Specific 60 Molecular Mechanisms 60 Analytical Tool 60 Estrogen Receptor 60 Protein Interactions 60 Proteasome 60 Therapeutic Potential 60 Pathway Inhibitor 60 Peripheral Blood 60 Androgen Receptor 59 Histone Deacetylase 59 Immunotherapeutic 59 Refractory Angina 59 Personalized Immunotherapy 59 SGLT2 59 RNase L 59 Targeted Therapies 59 CXCR7 59 Cell Lymphoma 59 Kinase 59 Pathogenesis 59 Oligonucleotide 59 Nuclear Receptors 59 MKC# MKC# PP 59 Advanced Renal Cell 59 Preclinical Data 59 Regenerative Cells 59 Renal Cell Carcinoma 59 Antisense 59 Gastric Cancer 59 Malignant Melanoma 59 Glioma 59 Inflammatory Arthritis 59 Fibrinogen 59 Cytotoxic T 59 Microplasmin 59 Inflammatory Diseases 59 Vascular Targeting Agents 59 Epidermal Growth Factor Receptor 59 Protein Expression 59 phosphate S1P 59 Universal Flu Vaccine 59 Beta Amyloid 59 ARRY # 59 Thyroid Hormone 59 Metastases 59 Wnt beta catenin 59 Endothelial Cells 59 Metastasis 59 Upregulation 59 BZL# 59 Novel Therapeutic 59 druggable targets 59 Mimetics 59 Phase 2a Clinical Trial 59 Oligonucleotides 59 Inflammation 59 Oral Mucositis 59 Myelodysplastic Syndromes 59 Extracellular Matrix 59 Immunomodulatory 59 Amyloid 59 neovascularization 59 MicroRNA 59 Protein Therapeutics 59 neurotrophic 59 Vascular Endothelial Growth 59 TGF Beta 59 Ovarian Cancer Patients 59 Autologous 59 Drug Pipeline 59 Brain Tumor Therapy 59 Skeletal Muscle 59 Talabostat 59 Mutational 59 VEGF receptor 59 Immunosuppressive 59 Mouse Models 59 Mucosal 59 RNAi therapeutic targeting 59 PDE# 59 fosbretabulin 59 Progenitor Cell 59 targeted antifolate 58 Hypercholesterolemia 58 coagulation cascade 58 inhibit angiogenesis 58 Phosphorylation 58 Novel Oral 58 Monoclonal Antibodies 58 Initiates Clinical 58 activin 58 depsipeptide 58 Platelet Derived Growth 58 Inactivation 58 Anticancer Drug 58 Chronic Lymphocytic Leukemia 58 Tumor Targeting 58 Innate Immunity 58 Protein Linked 58 Acute Heart Failure 58 Gastrointestinal Stromal Tumors 58 Oncogenic 58 Tissue Engineering 58 antisense inhibitors 58 DXL# 58 serine protease 58 Inflammatory Disease 58 Allogeneic 58 Novel Treatments 58 HDL Selective Delipidation 58 Inhibits 58 Bortezomib 58 vascular disrupting agent 58 targeting CD# 58 Glucocorticoid 58 Tumor Angiogenesis 58 Drug Prevents 58 Glycosylation 58 Therapeutic Effects 58 Hematological Malignancies 58 Protein Kinase C 58 Metastatic Melanoma 58 Osteopontin 58 mediated inhibition 58 Cardiotoxicity 58 anti CD3 58 Glycoprotein 58 Risk Stratification 58 Antisense Oligonucleotides 58 Neoplasms 58 antiproliferative effects 58 Tumor Growth 58 Preclinical Evaluation 58 Clinical Trial Results 58 molecularly targeted 58 Preclinical Models 58 Phase III Pivotal 58 rxRNA 58 Novel Approaches 58 Novel Mechanism 58 Tumor Necrosis Factor 58 cyclooxygenase 2 58 pigment epithelium derived 58 Neurodegenerative Disease 58 Cannabinoid 58 Genetic Variation 58 Leukemias 58 Potent Anti 58 targeted radiotherapeutic 58 small molecule agonists 58 Translational 58 CENP E 58 Sangamo BioSciences Announces 58 Amyloid beta 58 Hematopoietic Stem Cells 58 Tumour Vascular Disrupting Agent 58 S#P# 58 Diabetic Neuropathy 58 ASCO GU 58 Dasatinib 58 Mouse Model 58 monocytes macrophages 58 Diabetic Nephropathy 58 Anticancer Agent 58 tissue fibrosis 58 Cetrorelix 58 Dose Response 58 NPC 1C 58 tumor angiogenesis 58 Atopic Dermatitis 58 Protein Involved 58 Integrin 58 Neurogenic 58 Recombinant Protein 58 Drug Candidate 58 antiangiogenic 58 Metastatic 58 Neuroendocrine Tumor 58 Decitabine 57 Cytotoxic 57 Bucindolol 57 vinca alkaloid 57 Fibroblast Growth Factor 57 Carcinomas 57 Bladder Cancer 57 Molecular Basis 57 hedgehog signaling pathway 57 TGF ß 57 Immunosuppression 57 OMP #R# 57 Retrovirus 57 Shows Promise Against 57 Fabry Disease 57 Denufosol 57 adhesion molecule 57 potent suppressor 57 Nerve Regeneration 57 Monoclonal 57 Nicotinic 57 investigational humanized monoclonal antibody 57 Gamma secretase 57 NS5A 57 antimetastatic 57 Tumor Suppressor Gene 57 TGF beta1 57 Malignancies 57 Therapeutic Vaccine 57 C5aR 57 Liver Cancer 57 protein tyrosine phosphatase 1B 57 Epithelium 57 Phase III Clinical Trial 57 kidney urologic 57 Cytotoxicity 57 Drug Shows Promise 57 Therapeutic Efficacy 57 JAK2 Inhibitor 57 Cancer Therapies 57 JAK Inhibitor 57 triggers apoptosis 57 Microtubule 57 adipogenic 57 NSCLC tumors 57 ENMD # 57 P#X# 57 Novel Antibody 57 Therapeutic Vaccines 57 Mesenchymal 57 Novel Inhibitor 57 trial evaluating PRX# 57 BiTE 57 Myeloid 57 Lysosomal 57 Gene Mutation 57 epigenetic therapies 57 Symadex 57 Immunotherapy 57 Oxidative Stress 57 Transmembrane 57 CCR1 57 Galectin 57 siRNA Delivery 57 Multicenter Randomized 57 Anti Angiogenic 57 Biomarkers 57 small molecule activator 57 Neuroprotective 57 Epigenetic 57 HIF 1α 57 uPA 57 NS4B 57 Antitumor Activity 57 Solid Tumor 57 Stem Cell Differentiation 57 Dysregulation 57 hematopoiesis 57 Cytochrome P# 57 Atherosclerosis 57 Neurodegeneration 57 proteasome inhibition 57 Epithelial Cell 57 Prolongs Survival 57 Malignant Mesothelioma 57 Stapled Peptide 57 EGFr 57 PI3K Akt 57 Eg5 57 Inflammatory Markers 57 Iron Overload 57 hedgehog pathway 57 Camptothecin 57 Bafetinib 57 Viral Infections 57 Oncolytic Reovirus 57 Islet Transplantation 57 HuMax TAC 57 CYT# potent vascular disrupting 57 VEGF vascular endothelial 57 Biomarker Study 57 Adult Stem Cell Therapy 57 CCX# 57 nicotinic acetylcholine receptor 57 Ion Channels 57 Biomarker 57 inhibiting angiogenesis 57 MT#/MEDI-# 57 TÎ ² 4 57 Morpholino 57 Cytokines 57 Preclinical Development 57 Cotara ® 57 Antigens 57 Xenograft 57 Present Preclinical Data 57 COX2 57 Preclinical Efficacy 57 Recombinant Human 57 derived neurotrophic factor 57 anti angiogenesis 57 Antisense Drug 57 Anthracycline 57 angiogenesis inhibitor 57 pro angiogenic 57 Renal Cancer 57 Cell Signaling 57 Modulates 57 Induced Pluripotent Stem Cells 57 potent antiproliferative 57 Pertuzumab 56 Alvine Pharmaceuticals 56 CCR9 56 Hormone Refractory Prostate Cancer 56 Epitopes 56 small molecule activators 56 Transdermal Delivery 56 EVIZON TM 56 Neuronal 56 Axonal 56 Transgenic Mice 56 inhibit metastasis 56 hypoxia inducible factor 56 Atiprimod 56 Epitope 56 LPA1 56 Nucleic Acids 56 gastrin 56 Nerve Cell 56 reversible inhibitors 56 renal fibrosis 56 Enzastaurin 56 TPO receptor 56 Photodynamic Therapy 56 Hedgehog Pathway 56 FGFR3 56 Cancer Immunotherapy 56 proto oncogene 56 Pivotal Trial 56 Cell Proliferation 56 Scientists Identify 56 MEK ERK 56 immune modulator 56 Dupuytren Contracture 56 antibody MT# 56 Clinical Trial Data 56 receptor tyrosine kinase inhibitor 56 Anti Phospholipid Therapy 56 Coronary Arteries 56 E#F# 56 Catenin 56 HDL Mimetic Peptide 56 Cathepsin S 56 fast skeletal troponin 56 Phase III Clinical Trials 56 Soluble CD# 56 Nedd4 56 fatty acid biosynthesis 56 Myelofibrosis 56 PROSTASCINT R 56 Fibroblasts 56 protein homeostasis 56 Incretin 56 Alu RNA 56 cAMP signaling 56 Phase 2b Trial 56 Anti Tumor Activity 56 Lung Cancer Drug 56 eNOS 56 Bruton tyrosine kinase 56 Proteases 56 Monoclonal Antibody 56 Aggressive Reduction 56 Adenoma 56 Disease Progression 56 Phase 2a Trial 56 Lung Cancers 56 organogenesis 56 Advanced Melanoma 56 Carcinoma 56 FGFR1 56 TRO# 56 Carfilzomib 56 immunoregulatory 56 IMC A# 56 Histone 56 Apoptotic 56 Inflammatory Bowel Diseases 56 Fas ligand 56 cMET 56 Aplidin R 56 Aldosterone 56 Chemotherapeutic Agents 56 Methylation 56 Replacement Therapy 56 Genetic Basis 56 Ridaforolimus 56 Pivotal Clinical Trial 56 Biomarker Discovery 56 Safinamide 56 Dose Escalation 56 G Protein Coupled 56 CD#L 56 glycosyltransferase 56 Drug Discovery 56 Myocardial Ischemia 56 Breast Tumors 56 YONDELIS 56 Cutaneous T 56 novel peptides 56 Autoimmune Disorders 56 Angiotensin II 56 C5a 56 myogenesis 56 PDGFR 56 peroxisome proliferator activated 56 mda 7 56 RNA splicing 56 CA4P 56 Cachexia 56 Small Molecules 56 Vascular endothelial growth 56 Liposomal 56 vivo validation 56 apoptotic pathway 56 neurite outgrowth 56 Fast Skeletal Troponin 56 Inhibitory 56 vWF 56 intracellular signaling 56 Corgentin 56 Drug Metabolism 56 Oral Fingolimod 56 5 HT6 receptor 56 Immune Cell 56 DGAT1 56 Septic Shock 56 neuronal nicotinic receptors NNRs 56 DNA intercalator 56 EGFR pathway 56 Pemphigus Vulgaris 56 IGFBP2 56 vascular endothelial 56 Hedgehog Pathway Inhibitor 56 Receptor Antagonist 56 Peroxisome Proliferator Activated Receptor 56 Galectin 3 56 Neuropeptide Y 56 Stomach Cancer 56 Elagolix 56 osteoclast 56 demethylating agents 56 prostaglandin synthesis 56 Adult Stem Cells 56 Lipoprotein 56 Cancer Cells 56 Demonstrates Potential 56 Diabetic Foot Ulcer 56 Mammalian Cells 56 suppresses tumor 56 Homeostasis 56 induces apoptosis 56 Neurodegenerative 56 pancreatic colon 56 molecular imaging radiopharmaceutical 56 DNA Methylation 56 Signal Transduction 56 Phenotype 56 PDX pralatrexate 56 Treating Chronic 56 tubulin polymerization 56 Omacetaxine 56 molecular biomarkers 56 Transcriptional 56 tumor microenvironment 56 Zebrafish 56 Allosteric 56 ASCO GI 56 Receives Orphan Drug 56 PDGF receptor 56 Trofex 56 Adjuvant Treatment 56 FGFR 56 Molecular Mechanism 56 Chronic Inflammation 56 IGF1R 56 Interferon Beta 56 R roscovitine 56 histone deacetylase inhibitors 56 Prostate Cancer Progression 56 oncogenesis 56 Clusterin 56 Metastatic Cancer 55 Genes Identified 55 ARVO 55 Phase IIb Clinical Trial 55 tyrosine phosphorylation 55 Nicotine Vaccine 55 Cathepsin B 55 Small Molecule Inhibitors 55 NV1FGF 55 Valve Replacement 55 Adenosine 55 Motility 55 Lymphocytes 55 cytoprotective 55 novel peptide 55 TGF β 55 Cellular Therapy 55 Erythropoietic 55 factor PlGF 55 kinase PI3K 55 Trophos 55 A3 adenosine receptor 55 Aurora kinase 55 keratinocyte 55 Novel Small Molecule 55 ZFP Therapeutic 55 Growth Hormone Deficiency 55 aurora kinase 55 mTOR mammalian target 55 Immune Mediated 55 Combination REOLYSIN R 55 Immune Responses 55 Human Neural Stem 55 IgG1 antibody 55 Newly Diagnosed 55 Renal Cell Cancer 55 Tesetaxel 55 antiangiogenesis 55 immuno modulatory 55 HDAC Inhibitors 55 Epratuzumab 55 AEG# 55 pancreatic islet cell 55 Romidepsin 55 Polymerase Inhibitor 55 Presents Preclinical Data 55 Androgen 55 LRP6 55 Hepatocytes 55 Gene Linked 55 antisense inhibitor 55 Cell Transplants 55 HDAC 55 Shows Promising 55 Researchers Identify 55 TRAIL receptors 55 receptors PPARs 55 Interferon Gamma 55 specific lectin receptors 55 mGluR2 NAM 55 Preclinical Studies 55 Phase Ib Clinical Trial 55 Breast Cancer Cells 55 PDGF B 55 EnVivo Pharmaceuticals 55 Neuroinflammation 55 Late Breaker 55 Peptide 55 Pooled Analysis 55 Pulmonary Arterial Hypertension 55 Pirfenidone 55 Genetic Mutation 55 Phase 1b Clinical Trial 55 SYN# 55 Potent Inhibitor 55 Ovarian Cancers 55 Exelixis XL# 55 B Raf 55 Tissue Repair 55 Lipid Metabolism 55 Transdermal Patch 55 proteasome inhibitor 55 Blood Vessel 55 protein tyrosine kinase 55 Meets Primary Endpoint 55 JAK1 55 PI3 kinase 55 Targeted Anticancer Therapies 55 Pharmacokinetic Study 55 IL# PE#QQR 55 Alfacell proprietary ribonuclease 55 Completes Patient Enrollment 55 Hematological Cancers 55 Antibody Discovery 55 Effective Treatments 55 Epstein Barr Virus EBV 55 endostatin 55 Fat Grafting 55 ALN TTR 55 delipidation 55 Collaborators Publish 55 Investigational Treatment 55 c myc gene 55 metastatic neuroendocrine tumors 55 Cathepsin K 55 factor receptor FGFR 55 Cell Lung Cancer 55 Mitochondrial Dysfunction 55 JAK3 55 Maven Semantic 55 Eukaryotic 55 Neural Stem Cells 55 Molecular Cancer 55 Guanilib 55 Aliskiren 55 Metastatic Renal Cell Carcinoma 55 Placebo Controlled Study 55 cardiac myosin motor 55 tyrosine kinase receptor 55 Tumor Response 55 INS# [001] 55 uricase 55 Histone deacetylase 55 Receptos 55 Interferon Alpha 55 Tß4 55 Hepatocyte 55 phosphoinositide 3 55 angiogenesis inhibitors 55 Chemokine 55 Hypoxia Inducible Factor 55 PI3 Kinase 55 Initiates Clinical Trial 55 Inhibitors 55 Aromatase 55 Malaria Vaccine 55 JAK STAT 55 protein kinase inhibitors 55 Hedgehog signaling 55 Protein Interaction 55 TGF b 55 Investigational Drug 55 AACR NCI EORTC 55 Zinc Finger Nucleases 55 humanized monoclonal 55 3 kinase PI3K 55 anti fibrotic 55 MGd 55 NFkB 55 Stem Cell Transplant 55 Gene Mutations 55 potently inhibit 55 nicotinic alpha 7 55 P#Y# [001] 55 Tubulin 55 Radiation Induced 55 Cancer Biomarkers 55 regulated kinase ERK 55 Induces Apoptosis 55 Genes Involved 55 Antiviral Activity 55 Oral Presentations 55 Randomized Double blind 55 transdifferentiation 55 miRagen 55 Degarelix 55 II Clinical Trial 55 BAL# [001] 55 Enrolling Patients 55 DNA hypermethylation 55 First Patient Enrolled 55 Immunotherapies 55 Receptor Antagonists 55 Toxicogenomics 55 nitric oxide synthase 55 Receptor Signaling 55 Polymorphisms 55 chimeric monoclonal antibody 55 Gastrointestinal Cancers 55 Chronic Lymphocytic Leukemia CLL 55 Dehydrogenase 55 Exherin TM 55 HCV replication 55 EORTC NCI 55 histone deacetylase HDAC inhibitor 55 signaling cascades 55 Bone Morphogenetic Protein 55 orally administered inhibitor 55 PSN# [002] 55 epithelial mesenchymal transition 55 TXNIP 55 Nanobody 55 apoptosis inducing 55 5 HT4 55 small molecule Hedgehog 55 Tanespimycin 55 Reports Preclinical Data 55 Initiates Enrollment 55 Vascugel 55 Dendritic cell 55 Mutagenesis 55 Patient Enrollment 55 Bionanotechnology 55 c MET 55 Artificial Pancreas 55 HIV Integrase 55 kinase pathway 55 Smoothened 55 Endometrial 55 Tumor Progression 55 Lpathomab 55 Orphan Diseases 55 FVIIa 55 Topical Treatment 55 ZYBRESTAT TM 55 antibody mediated 55 Aneuploidy 55 Adjuvant Breast Cancer 55 TACI Ig 55 RAV# 55 alpha#beta# integrin 55 chromatin remodeling 55 oral JAK1 55 Anti CD# Antibody 55 Antibody 55 Bone Marrow Stem Cells 55 Personalised Medicine 55 cathepsins 55 Trastuzumab DM1 55 eIF 4E 55 factor HGF 55 Malignancy 55 Cloretazine R 55 deacetylase inhibitors 55 Autologous Stem Cell Transplantation 55 Phosphatase 55 Image Guided 55 IND Filing 55 HepaSphere 55 Proliferative 55 PI3 kinase inhibitors 55 Phase 2b Study 55 NF kB pathway 55 Anti Infectives 55 Pivotal Trials 55 IAP inhibitor 55 Neural Stem Cell 55 PML RARA 55 Flt3 55 Survivin 55 Chronic Pelvic Pain 54 Bone Metastases 54 AFREZZA TM 54 selective kinase inhibitor 54 Epidermal Growth Factor 54 transgenic mouse models 54 AMD# [003] 54 agonist compounds 54 Epigenome 54 adult mesenchymal stem 54 annexin 54 MLN# 54 cardiac hypertrophy 54 oncomodulin 54 Phase III Trial 54 Microbicide 54 Lumbar Spine 54 ProLindac TM 54 anti secretory 54 adrenomedullin 54 Gene Expression 54 RAS RAF MEK 54 Hippocampal 54 MAP kinase pathway 54 Improves Survival 54 ON #.Na 54 Sphingomab 54 pan HDAC inhibitor 54 angiogenic 54 Squamous Cell Carcinoma 54 p# mitogen activated 54 FOXO3a 54 Phase #b/#a clinical 54 tumor metastasis 54 Demonstrates Efficacy 54 VEGF inhibitors 54 Stem Cell Therapies 54 enzyme inhibitors 54 TGFβ 54 p# MAP kinase 54 Pulmonary Hypertension 54 Cancer Therapeutic 54 angiogenesis inhibition 54 Demonstrates Positive 54 hepatoma 54 Angiolix 54 Wnt signaling pathway 54 ERK pathway 54 remyelination 54 antiapoptotic 54 isoform selective 54 Ataluren 54 Angiocept 54 ZFP TF 54 Carcinoid 54 DNA methyltransferases 54 adipogenesis 54 Thromboembolic 54 Activity Assay 54 Panzem 54 neuroprotection 54 Gastrointestinal Disorders 54 Neoadjuvant Chemotherapy 54 Antibody Drug Conjugate 54 Solid Tumors 54 Unresectable 54 Bazedoxifene 54 CCR2 54 Slow Progression 54 Cardiomyocytes 54 Randomized Clinical Trial 54 TNFalpha 54 Receptor Agonist 54 compound CTCE 54 Molecular Diagnostic 54 sunitinib Sutent 54 ERK1 2 54 Oocyte 54 acetylcholinesterase AChE 54 Oral Cavity 54 Blood Vessels 54 Autoimmune 54 Antiviral Therapy 54 Intracellular 54 HCV polymerase 54 Antibody Therapeutics 54 PXD# 54 antimitotic 54 PNP inhibitor 54 Randomized Phase 54 Pivotal Study 54 Chimeric 54 Lung Cancer Screening 54 LHON 54 Bevasiranib 54 therapeutic monoclonal antibody 54 prostaglandin D2 54 Metabolomics 54 Breast Cancer Stem Cells 54 Neural Circuits 54 See CLINICAL PHARMACOLOGY 54 predictive toxicology 54 synthetases 54 Metastatic Prostate Cancer 54 gastro intestinal inflammation 54 polycythemia vera PV 54 ERK signaling 54 Anticancer Drugs 54 Gene Expression Profiling 54 AS# amonafide L malate 54 Retinoic Acid 54 investigational therapies 54 soluble receptor 54 Susceptibility Gene 54 sphingosine 1 54 mTOR signaling 54 Placebo Controlled Trial 54 NABTT 54 LPA1 receptor 54 adipose derived regenerative 54 PIK3CA 54 endothelin receptor 54 fibrin deposition 54 NKX#.# 54 receptor tyrosine kinase 54 PEG SN# 54 PI3K 54 Randomized Study 54 cellular pathways 54 Hepatocellular 54 Epigenetics 54 pralatrexate injection folate analogue 54 Crystallographic 54 cyclic adenosine monophosphate cAMP 54 Pegylated 54 AT1R 54 Oncogene 54 eIF2 54 CR# vcMMAE 54 vaccine GRNVAC1 54 Anticalin ® 54 Senescence 54 Phenotyping 54 Heart Transplant Recipients 54 novel VDA molecule 54 Polymorphism 54 Tumor Cells 54 Successfully Completes Phase 54 Autoantibodies 54 β catenin 54 Outpatient Setting 54 PI3K/Akt 54 morphogenesis 54 PKC beta 54 Tissue Factor